Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine

Stumpf, Julian; Siepmann, Torsten; H. Lindner, Tom; Karger, Claudia; Schwöbel, Jörg; Anders, Leona; Faulhaber‐Walter, Robert; Schewe, J.-C.; Martin, Heike; Schirutschke, Holger; Barnett, Kerstin; Hüther, Jan; Müller, Petra; Langer, Torsten; Pluntke, Thilo; Anding‐Rost, Kirsten; Meistring, Frank; Stehr, Thomas; Pietzonka, Annegret; Escher, Katja; Cerny, Simon; Rothe, H.; Pistrosch, Frank; Seidel, Harald; Paliege, Alexander; Beige, Joachim; Bast, Ingolf; Steglich, Anne; Gembardt, Florian; Kessel, Friederike; Kröger, Hannah; Arndt, Patrick; Sradnick, Jan; Frank, Kerstin; Klimová, Anna; Mauer, René; Grählert, Xina; Anft, Moritz; Blazquez‐Navarro, Arturo; H. Westhoff, Timm; Stervbo, Ulrik; Tonn, Torsten; Babel, Nina; Hugo, Christian

doi:10.1016/j.lanepe.2021.100178

Public

Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine

Published in The Lancet Regional Health - Europe • Jul 23, 2021

Authors:

Julian Stumpf

Torsten Siepmann

Tom H. Lindner

Abstract

Dialysis and kidney transplant patients are vulnerable populations for COVID-19 related disease and mortality. We conducted a prospective study exploring the eight week time course of specific cellular (interferon-γ release assay and flow cytometry) or/and humoral immune responses (ELISA) to SARS-Co...

Subject

Seroconversion

Medicine

Dialysis

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!